The trademark ZYBUTRIN was filed by Sun Pharmaceutical Industries Limited, a corporation established under the laws of the Republic of India (the "Applicant"). The application was published for oppositions on October 8, 2023, and received one opposition filed on November 29, 2023 by GLAXO GROUP LIMITED on Likelihood of confusion. the opponent was represented by ZIVKO MIJATOVIC & PARTNERS and proceedings were handled in English, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued November 29, 2023
The application was filed in English, and English was also language of all opposition proceedings (German was selected as the second language).